MARABEX Trademark

Trademark Overview

On Monday, November 17, 2014, a trademark application was filed for MARABEX with the United States Patent and Trademark Office. The USPTO has given the MARABEX trademark a serial number of 86456221. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, August 7, 2020. This trademark is owned by Turnstone Biologics Inc.. The MARABEX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Oncolytic viruses, namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases; pharmaceutical and vaccine products in the field of cancer and infectious diseases

Research and development in connection with oncolytic viruses and oncolytic vaccines, viral vectors; pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases; pharmaceutical and vaccine products in the field of cancer and infectious disease
marabex

General Information

Serial Number86456221
Word MarkMARABEX
Filing DateMonday, November 17, 2014
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, August 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesOncolytic viruses, namely, oncolytic vaccines, viral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases; pharmaceutical and vaccine products in the field of cancer and infectious diseases
Goods and ServicesResearch and development in connection with oncolytic viruses and oncolytic vaccines, viral vectors; pharmaceutical compounds and products in the field of cancer and infectious diseases, antibodies in the field of cancer and infectious diseases, protein and peptide products in the field of cancer and infectious diseases; pharmaceutical and vaccine products in the field of cancer and infectious disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 24, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 24, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTurnstone Biologics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1B8
CA

Trademark Events

Event DateEvent Description
Friday, August 7, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, August 7, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2020NON-FINAL ACTION WRITTEN
Monday, December 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 19, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 12, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, September 12, 2019INQUIRY TO SUSPENSION E-MAILED
Thursday, September 12, 2019SUSPENSION INQUIRY WRITTEN
Wednesday, August 28, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, August 15, 2019ASSIGNED TO LIE
Tuesday, August 6, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 14, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 2, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 2, 2018ASSIGNED TO LIE
Monday, January 22, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 22, 2018LETTER OF SUSPENSION E-MAILED
Monday, January 22, 2018SUSPENSION LETTER WRITTEN
Friday, January 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 17, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 22, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 22, 2017INQUIRY TO SUSPENSION E-MAILED
Friday, December 22, 2017SUSPENSION INQUIRY WRITTEN
Tuesday, December 12, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, June 7, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 7, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, June 7, 2017SUSPENSION LETTER WRITTEN
Wednesday, June 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 5, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 15, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Saturday, June 11, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, June 11, 2016LETTER OF SUSPENSION E-MAILED
Saturday, June 11, 2016SUSPENSION LETTER WRITTEN
Thursday, May 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 19, 2016ASSIGNED TO LIE
Monday, May 9, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 23, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, November 23, 2015INQUIRY TO SUSPENSION E-MAILED
Monday, November 23, 2015SUSPENSION INQUIRY WRITTEN
Monday, November 2, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, November 2, 2015ASSIGNED TO LIE
Friday, May 1, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 1, 2015LETTER OF SUSPENSION E-MAILED
Friday, May 1, 2015SUSPENSION LETTER WRITTEN
Thursday, April 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 30, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 30, 2015ASSIGNED TO LIE
Tuesday, April 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 14, 2015NON-FINAL ACTION E-MAILED
Saturday, March 14, 2015NON-FINAL ACTION WRITTEN
Saturday, March 7, 2015ASSIGNED TO EXAMINER
Monday, November 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 20, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

marabex field cancer infectious diseases products oncolytic pharmaceutical protein peptide antibodies